Negative effect of parecoxib on bone mineral during fracture healing in rats

References

• Aspenberg P. Avoid cox inhibitors after skeletal surgery!. Acta Orthop Scand 2002; 73(5)489–90
   PubMed Web of Science ®Google Scholar
• Aspenberg P. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2004; 22(3)684–author reply 685
   PubMed Web of Science ®Google Scholar
• Beck A, Krischak G, Sorg T, Augat P, Farker K, Merkel U, Kinzl L, Claes L. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003; 123(7)327–32
   PubMed Web of Science ®Google Scholar
• Bergenstock M, Min W, Simon A M, Sabatino C, O'Connor J P. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. J Orthop Trauma 2005; 19(10)717–23
   PubMed Web of Science ®Google Scholar
• Brown K M, Saunders M M, Kirsch T, Donahue H J, Reid J S. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg (Am) 2004; 86(1)116–23
   PubMed Web of Science ®Google Scholar
• Dahl V, Dybvik T, Steen T, Aune A K, Rosenlund E K, Raeder J C. Ibuprofen vs. acetaminophen vs. ibuprofen and acetaminophen after arthroscopically assisted anterior cruciate ligament reconstruction. Eur J Anaesthesiol 2004; 21(6)471–5
   PubMed Web of Science ®Google Scholar
• Dahners L E, Mullis B H. Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 2004; 12(3)139–43
   PubMed Web of Science ®Google Scholar
• Desjardins P J, Grossman E H, Kuss M E, Talwalker S, Dhadda S, Baum D, Hubbard R C. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 2001; 93(3)721–7
   PubMed Web of Science ®Google Scholar
• Dubois R N, Abramson S B, Crofford L, Gupta R A, Simon L S, Van De Putte L B, Lipsky P E. Cyclooxygenase in biology and disease. Faseb J 1998; 12(12)1063–73
   PubMed Web of Science ®Google Scholar
• Einhorn T A. Do inhibitors of cyclooxygenase-2 impair bone healing?. J Bone Miner Res 2002; 17(6)977–8
   PubMed Web of Science ®Google Scholar
• Ekeland A, Engesaeter L B, Langeland N. Mechanical properties of fractured and intact rat femora evaluated by bending, torsional and tensile tests. Acta Orthop Scand 1981; 52(6)605–13
   PubMed Web of Science ®Google Scholar
• Endo K, Sairyo K, Komatsubara S, SasaT, Egawa H, Ogawa T, Yonekura D, Murakami R, Yasui N. Cyclooxygenase 2 inhibitor delays fracture healing in rats. Acta Orthop 2005; 76(4)470–4
   PubMed Web of Science ®Google Scholar
• Engesaeter L B, Sudmann B, Sudmann E. Fracture healing in rats inhibited by locally administered indomethacin. Acta Orthop Scand 1992; 63(3)330–3
   PubMed Web of Science ®Google Scholar
• Fogarty D J, O'Hanlon J J, Milligan K R. Intramuscular ketorolac following total hip replacement with spinal anaesthesia and intrathecal morphine. Acta Anaesthesiol Scand 1995; 39(2)191–4
   PubMed Web of Science ®Google Scholar
• Gan T J, Joshi G P, Viscusi E, Cheung R Y, Dodge W, Fort J G, Chen C. Preoperative parenteral parecoxib and follow up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery. Anesth Analg 2004; 98(6)1665–73, table of contents
   PubMed Web of Science ®Google Scholar
• Gerstenfeld L C, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn T A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003; 21(4)670–5
   PubMed Web of Science ®Google Scholar
• Gerstenfeld L C, Al-Ghawas M, Alkhiary Y M, Cullinane D M, Krall E A, Fitch J L, Webb E G, Thiede M A, Einhorn T A. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg (Am) 2007; 89(1)114–25
   PubMed Web of Science ®Google Scholar
• Gillies G W, Kenny G N, Bullingham R E, McArdle C S. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987; 42(7)727–31
   PubMed Web of Science ®Google Scholar
• Halpin R A, Geer L A, Zhang K E, Marks T M, Dean D C, Jones A N, Melillo D, Doss G, Vyas K P. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Drug Metab Dispos 2000; 28(10)1244–54
   PubMed Web of Science ®Google Scholar
• Hogevold H E, Grogaard B, Reikeras O. Effects of shortterm treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 1992; 63(6)607–11
   PubMedGoogle Scholar
• Hubbard R C, Naumann T M, Traylor L, Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 2003; 90(2)166–72
   PubMed Web of Science ®Google Scholar
• Huntjens D R, Danhof M, Della Pasqua O E. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Rheumatology (Oxford) 2005; 44(7)846–59
   PubMed Web of Science ®Google Scholar
• Keller J, Bayer-Kristensen I, Bak B, Bunger C, Kjaersgaard Andersen P, Lucht U, Melsen F. Indomethacin and bone remodeling. Effect on cortical bone after osteotomy in rabbits. Acta Orthop Scand 1989; 60(1)119–21
   PubMed Web of Science ®Google Scholar
• Kranke P, Morin A M, Roewer N, Eberhart L H. Patients’ global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg 2004; 99(3)797–806, table of contents
   PubMed Web of Science ®Google Scholar
• Leese P T, Hubbard R C, Karim A, Isakson P C, Yu S S, Geis G S. Effects of celecoxib, a novel cyclooxygenase 2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40(2)124–32
   PubMed Web of Science ®Google Scholar
• Madsen J E, Hukkanen M, Aune A K, Basran I, Moller J F, Polak J M, Nordsletten L. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop 1998, 351: 230–40
   PubMed Web of Science ®Google Scholar
• Malan T P, Jr, Marsh G, Hakki S I, Grossman E, Traylor L, Hubbard R C. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology 2003; 98(4)950–6
   PubMed Web of Science ®Google Scholar
• McLoughlin C, McKinney M S, Fee J P, Boules Z. Diclofenac for day-care arthroscopy surgery: comparison with a standard opioid therapy. Br J Anaesth 1990; 65(5)620–3
   PubMed Web of Science ®Google Scholar
• Meunier A, Aspenberg P. Parecoxib impairs early metaphy seal bone healing in rats. Arch Orthop Trauma Surg 2006; 126(7)433–6
   PubMed Web of Science ®Google Scholar
• Mullis B H, Copland S T, Weinhold P S, Miclau T, Lester G E, Bos G D. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury 2006; 37(9)827–37
   PubMed Web of Science ®Google Scholar
• Nordsletten L, Skjeldal S, Kirkeby O J, Ekeland A. Muscle contraction increases the strength of healing tibial fracture in the rat. Acta Orthop Scand 1994; 65(2)191–4
   PubMed Web of Science ®Google Scholar
• Okada Y, Lorenzo J A, Freeman A M, Tomita M, Morham S G, Raisz L G, Pilbeam C C. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 2000; 105(6)823–32
   PubMed Web of Science ®Google Scholar
• Paulson S K, Zhang J Y, Breau A P, Hribar J D, Liu N W, Jessen S M, Lawal Y M, Cogburn J N, Gresk C J, Markos C S, Maziasz T J, Schoenhard G L, Burton E G. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Drug Metab Dispos 2000; 28(5)514–21
   PubMed Web of Science ®Google Scholar
• Rasmussen G L, Steckner K, Hogue C, Torri S, Hubbard R C. Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. Am J Orthop 2002; 31(6)336–43
   PubMedGoogle Scholar
• Rø J, Sudmann E, Marton P F. Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 1976; 47(6)588–99
   PubMed Web of Science ®Google Scholar
• Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 1994; 91(25)12013–7
   PubMed Web of Science ®Google Scholar
• Simon A M, Manigrasso M B, O'Connor J P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17(6)963–76
   PubMed Web of Science ®Google Scholar
• Simon A M, O'Connor J P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg (Am) 2007; 89(3)500–11
   PubMed Web of Science ®Google Scholar
• Stichtenoth D O, Frolich J C. The second generation of COX-2 inhibitors: what advantages do the newest offer?. Drugs 2003; 63(1)33–45
   PubMed Web of Science ®Google Scholar
• Sudmann E, Dregelid E, Bessesen A, Morland J. Inhibition of fracture healing by indomethacin in rats. Eur J Clin Invest 1979; 9(5)333–9
   PubMed Web of Science ®Google Scholar
• Talley J J, Bertenshaw S R, Brown D L, Carter J S, Graneto M J, Kellogg M S, Koboldt C M, Yuan J, Zhang Y Y, Seibert K. N-[[(5-methyl-3-phenylisoxazol-4-yl)-pheny l]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration. J Med Chem 2000; 43(9)1661–3
   PubMed Web of Science ®Google Scholar
• Weber E W, Slappendel R, Durieux M E, Dirksen R, van der Heide H, Spruit M. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 2003; 20(12)963–6
   PubMed Web of Science ®Google Scholar
• Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109(11)1405–15
   PubMed Web of Science ®Google Scholar